Literature DB >> 28590966

CHARACTERISTICS OF EPIRETINAL MEMBRANE REMNANT EDGE BY OPTICAL COHERENCE TOMOGRAPHY AFTER PARS PLANA VITRECTOMY.

Raouf Gaber1, Qi Sheng You, Ilkay Kilic Muftuoglu, Mostafa Alam, Frank F Tsai, Nadia Mendoza, William R Freeman.   

Abstract

PURPOSE: To evaluate the incidence, characteristics, and the progression of epiretinal membrane (ERM) remnant edge seen by optical coherence tomography after ERM peeling.
METHODS: A retrospective chart review was conducted for 86 eyes of 85 consecutive patients who were diagnosed with ERM and underwent pars plana vitrectomy for epiretinal membrane peeling between 2013 and 2014. Data collected and analyzed included age, gender, preoperative and postoperative visual acuity, use of indocyanine green dye to stain internal limiting membrane, tamponade used after vitrectomy, ERM edge boundaries, presence of cystoid macular edema, and central foveal thickness.
RESULTS: An ERM remnant edge was detected in 33/86 study eyes (38.4%) at the first postoperative optical coherence tomography scan. Compared with those without an ERM remnant, patients with an ERM remnant after surgery were significantly older at baseline and had a higher incidence of ERM recurrence at their last visit. They were not significantly different in terms of gender, preoperative and postoperative visual acuity, reduction of central foveal thickness from baseline, proportion of eyes with preoperative ERM elevation on optical coherence tomography, presence of macular edema before surgery, intraoperative use of indocyanine green staining for ILM peeling, or tamponade used. Based on the edge morphology, we classified the ERM remnant into three types: Type 1 was flat and blended with the retina (14/33 eyes, 42.4%), Type 2 was flat but stepped (17/33 eyes, 51.5%), and Type 3 was elevated (2/33 eyes, 6.0%). A significantly higher risk of ERM recurrence was seen in Type 2 and Type 3 ERM remnants (75% and 100%, respectively) than Type 1 ERM remnants (10%).
CONCLUSION: An ERM remnant edge was detected by optical coherence tomography after ERM peeling in 38.4% of eyes. The presence of a postoperative ERM edge was associated with a higher risk of ERM recurrence, particularly in Type 2 and Type 3 ERM remnants.

Entities:  

Mesh:

Year:  2017        PMID: 28590966      PMCID: PMC5505813          DOI: 10.1097/IAE.0000000000001466

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  18 in total

1.  Residual cellular proliferation on the internal limiting membrane in macular pucker surgery.

Authors:  Arnd Gandorfer; Christos Haritoglou; Renate Scheler; Ricarda Schumann; Fei Zhao; Anselm Kampik
Journal:  Retina       Date:  2012-03       Impact factor: 4.256

2.  Characterization of diabetic microaneurysms by simultaneous fluorescein angiography and spectral-domain optical coherence tomography.

Authors:  Haiyan Wang; Jay Chhablani; William R Freeman; Candy K Chan; Igor Kozak; Dirk-Uwe Bartsch; Lingyun Cheng
Journal:  Am J Ophthalmol       Date:  2012-02-01       Impact factor: 5.258

3.  THE ROYAL COLLEGE OF OPHTHALMOLOGISTS' NATIONAL OPHTHALMOLOGY DATABASE STUDY OF VITREORETINAL SURGERY: Report 4, Epiretinal Membrane.

Authors:  Timothy L Jackson; Paul H J Donachie; Tom H Williamson; John M Sparrow; Robert L Johnston
Journal:  Retina       Date:  2015-08       Impact factor: 4.256

4.  Surgery for epimacular membrane: impact of retinal internal limiting membrane removal on functional outcome.

Authors:  Etienne H Bovey; Sylvie Uffer; Farid Achache
Journal:  Retina       Date:  2004-10       Impact factor: 4.256

5.  Epiretinal membrane surgery with or without internal limiting membrane peeling.

Authors:  Alvin Kh Kwok; Timothy Yy Lai; Kenneth Sc Yuen
Journal:  Clin Exp Ophthalmol       Date:  2005-08       Impact factor: 4.207

6.  In vivo histology of cotton-wool spots using high-resolution optical coherence tomography.

Authors:  Igor Kozak; Dirk-Uwe Bartsch; Lingyun Cheng; William R Freeman
Journal:  Am J Ophthalmol       Date:  2006-04       Impact factor: 5.258

7.  Retinal adherence and fibrillary surface changes correlate with surgical difficulty of epiretinal membrane removal.

Authors:  Jae Suk Kim; Jay Chhablani; Candy K Chan; Lingyun Cheng; Igor Kozak; Kathrin Hartmann; William R Freeman
Journal:  Am J Ophthalmol       Date:  2011-12-03       Impact factor: 5.258

8.  Macular pucker removal with and without internal limiting membrane peeling: pilot study.

Authors:  Donald W Park; Pravin U Dugel; Jennifer Garda; Jack O Sipperley; Allen Thach; Scott R Sneed; Jennifer Blaisdell
Journal:  Ophthalmology       Date:  2003-01       Impact factor: 12.079

9.  ASSESSMENT OF THE SIGNIFICANCE OF CYSTIC CHANGES AFTER EPIRETINAL MEMBRANE SURGERY WITH INTERNAL LIMITING MEMBRANE REMOVAL.

Authors:  Rosa Dolz-Marco; Quan V Hoang; Roberto Gallego-Pinazo; Stanley Chang
Journal:  Retina       Date:  2016-04       Impact factor: 4.256

Review 10.  Optical coherence tomography in the preoperative and postoperative management of macular hole and epiretinal membrane.

Authors:  Roger A Goldberg; Nadia K Waheed; Jay S Duker
Journal:  Br J Ophthalmol       Date:  2014-03-13       Impact factor: 4.638

View more
  3 in total

Review 1.  [Statement of the Professional Association of German Ophthalmologists (BVA), the German Ophthalmological Society (DOG) and the Retinological Society (RG) on the development, diagnostics and treatment of epiretinal gliosis : Status October 2020].

Authors: 
Journal:  Ophthalmologe       Date:  2021-02       Impact factor: 1.059

2.  Comparison of Idiopathic Macular Hole Interventions Using Frequency Domain Optical Coherence Tomography and Optical Coherence Tomography Angiography.

Authors:  Miao Liu; Yu Jin; Liu Li; Fangxiu Yuan; Yueyuan Xu
Journal:  Dis Markers       Date:  2022-08-13       Impact factor: 3.464

3.  Long-term evaluation of spontaneous release of epiretinal membrane and its possible pathogenesis.

Authors:  Teruyo Kida; Seita Morishita; Masanori Fukumoto; Takaki Sato; Hidehiro Oku; Tsunehiko Ikeda
Journal:  Clin Ophthalmol       Date:  2017-09-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.